{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T17:08:56Z","timestamp":1787764136061,"version":"build-2784847793"},"reference-count":158,"publisher":"Oxford University Press (OUP)","issue":"58","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"vor","delay-in-days":4,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","award":["BX002807"],"award-info":[{"award-number":["BX002807"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000090","name":"Congressionally Directed Medical Research Program","doi-asserted-by":"crossref","award":["PC170059"],"award-info":[{"award-number":["PC170059"]}],"id":[{"id":"10.13039\/100000090","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the NIH","award":["R01CA239208"],"award-info":[{"award-number":["R01CA239208"]}]},{"name":"the NIH","award":["R01AG061558"],"award-info":[{"award-number":["R01AG061558"]}]},{"name":"the NIH","award":["R01AR067319"],"award-info":[{"award-number":["R01AR067319"]}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,11,28]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Cannabis and cannabinoids are increasingly being accessed and used by patients with advanced cancer for various symptoms and general quality of life. Specific symptoms of pain, nausea and vomiting, loss of appetite and cachexia, anxiety, sleep disturbance, and medical trauma are among those that have prompted patients with cancer to use cannabis. This conference report from the National Cancer Institute\u2019s \u201cCannabis, Cannabinoid and Cancer Research Symposium\u201d on the topic of \u201cCancer Symptom\/Treatment Side Effect Management\u201d is an expert perspective of cannabis intervention for cancer and cancer treatment-related symptoms. The purpose of the symposium was to identify research gaps, describe the need for high-quality randomized prospective studies of medical cannabis for palliative care in patients with cancer, and evaluate the impact of medical cannabis on cancer survivors\u2019 quality of life. Further, education of clinicians and affiliated health-care providers in guiding cancer patients in using cannabis for cancer care would benefit patients. Together, these steps will further aid in refining the use of cannabis and cannabinoids for symptom palliation and improve safety and efficacy for patients.<\/jats:p>","DOI":"10.1093\/jncimonographs\/lgab011","type":"journal-article","created":{"date-parts":[[2021,9,8]],"date-time":"2021-09-08T07:24:37Z","timestamp":1631085877000},"page":"86-98","source":"Crossref","is-referenced-by-count":33,"title":["The Management of Cancer Symptoms and Treatment-Induced Side Effects With Cannabis or Cannabinoids"],"prefix":"10.1093","volume":"2021","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0443-8355","authenticated-orcid":false,"given":"Michelle","family":"Sexton","sequence":"first","affiliation":[{"name":"Department of Anesthesiology, Division of Pain Management, University of California , San Diego, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose M","family":"Garcia","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Geriatrics, University of Washington and Geriatric Research Education and Clinical Center, Puget Sound Veterans Administration Health Care System , Seattle, WA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aminah","family":"Jatoi","sequence":"additional","affiliation":[{"name":"Department of Oncology, Mayo Clinic , Rochester, MN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carey S","family":"Clark","sequence":"additional","affiliation":[{"name":"Department of Nursing, Pacific College of Health and Science , San Diego, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark S","family":"Wallace","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Division of Pain Management, University of California , San Diego, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,11,27]]},"reference":[{"key":"2022112701101033700_lgab011-B1","volume-title":"Eclectic Materia Medica, Pharmacology and Therapeutics","author":"Felter","year":"1994"},{"issue":"12","key":"2022112701101033700_lgab011-B2","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0166-2236(98)01283-1","article-title":"Endocannabinoids: endogenous cannabinoid receptor ligands with neuromodulatory action","volume":"21","author":"Di Marzo","year":"1998","journal-title":"Trends Neurosci"},{"issue":"6","key":"2022112701101033700_lgab011-B3","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1177\/2045125312457586","article-title":"Cannabis, a complex plant: different compounds and different effects on individuals","volume":"2","author":"Atakan","year":"2012","journal-title":"Ther Adv Psychopharmacol"},{"issue":"3","key":"2022112701101033700_lgab011-B4","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1124\/pr.58.3.2","article-title":"The endocannabinoid system as an emerging target of pharmacotherapy","volume":"58","author":"Pacher","year":"2006","journal-title":"Pharmacol Rev"},{"key":"2022112701101033700_lgab011-B5","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.bcp.2018.08.046","article-title":"Cannabidiol skews biased agonism at cannabinoid CB1 and CB2 receptors with smaller effect in CB1-CB2 heteroreceptor complexes","volume":"157","author":"Navarro","year":"2018","journal-title":"Biochem Pharmacol"},{"issue":"7","key":"2022112701101033700_lgab011-B6","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1111\/j.1476-5381.2011.01238.x","article-title":"Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects","volume":"163","author":"Russo","year":"2011","journal-title":"Br J Pharmacol"},{"issue":"3","key":"2022112701101033700_lgab011-B7","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1124\/jpet.107.134809","article-title":"Plant-derived cannabinoids modulate the activity of transient receptor potential channels of ankyrin type-1 and melastatin type-8","volume":"325","author":"De Petrocellis","year":"2008","journal-title":"J Pharmacol Exp Ther"},{"issue":"4","key":"2022112701101033700_lgab011-B8","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/sj.bjp.0704327","article-title":"Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide","volume":"134","author":"Bisogno","year":"2001","journal-title":"Br J Pharmacol"},{"issue":"8","key":"2022112701101033700_lgab011-B9","doi-asserted-by":"crossref","first-page":"6347","DOI":"10.1007\/s12035-017-0833-7","article-title":"Cannabis users show enhanced expression of CB1-5HT2A receptor heteromers in olfactory neuroepithelium cells","volume":"55","author":"Galindo","year":"2018","journal-title":"Mol Neurobiol"},{"key":"2022112701101033700_lgab011-B10","doi-asserted-by":"crossref","first-page":"626010","DOI":"10.3389\/fphar.2021.626010","article-title":"Role of cannabidiol in the therapeutic intervention for substance use disorders","volume":"12","author":"Navarrete","year":"2021","journal-title":"Front Pharmacol"},{"issue":"1","key":"2022112701101033700_lgab011-B11","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1177\/0269881112460109","article-title":"Cannabidiol inhibits THC-elicited paranoid symptoms and hippocampal-dependent memory impairment","volume":"27","author":"Englund","year":"2013","journal-title":"J Psychopharmacol"},{"issue":"1-3","key":"2022112701101033700_lgab011-B12","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.schres.2015.01.033","article-title":"A systematic review of the antipsychotic properties of cannabidiol in humans","volume":"162","author":"Iseger","year":"2015","journal-title":"Schizophr Res"},{"issue":"3","key":"2022112701101033700_lgab011-B13","doi-asserted-by":"crossref","first-page":"210","DOI":"10.5152\/eurjrheum.2017.17025","article-title":"The endocannabinoid system in pain and inflammation: its relevance to rheumatic disease","volume":"4","author":"Barrie","year":"2017","journal-title":"Eur J Rheumatol"},{"issue":"23","key":"2022112701101033700_lgab011-B14","doi-asserted-by":"crossref","first-page":"4449","DOI":"10.1007\/s00018-016-2300-4","article-title":"The CB2 receptor and its role as a regulator of inflammation","volume":"73","author":"Turcotte","year":"2016","journal-title":"Cell Mol Life Sci"},{"issue":"5","key":"2022112701101033700_lgab011-B15","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.3390\/cancers13051058","article-title":"The prevalence and characteristics of breakthrough cancer pain in patients receiving low doses of opioids for background pain","volume":"13","author":"Mercadante","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"4","key":"2022112701101033700_lgab011-B16","doi-asserted-by":"crossref","first-page":"510","DOI":"10.3390\/cancers11040510","article-title":"Cancer pain assessment and classification","volume":"11","author":"Caraceni","year":"2019","journal-title":"Cancers (Basel)"},{"key":"2022112701101033700_lgab011-B17","volume-title":"WHO Analgesic Ladder","author":"Anekar","year":"2021"},{"issue":"3","key":"2022112701101033700_lgab011-B18","doi-asserted-by":"crossref","first-page":"182","DOI":"10.3322\/caac.21453","article-title":"Optimal pain management for patients with cancer in the modern era","volume":"68","author":"Scarborough","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"2022112701101033700_lgab011-B19","doi-asserted-by":"crossref","first-page":"675","DOI":"10.2147\/CEOR.S181192","article-title":"Burden of cancer pain in developing countries: a narrative literature review","volume":"10","author":"Li","year":"2018","journal-title":"Clinicoecon Outcomes Res"},{"key":"2022112701101033700_lgab011-B20","doi-asserted-by":"crossref","first-page":"S105","DOI":"10.36076\/ppj.2008\/11\/S105","article-title":"Opioid complications and side effects","volume":"11","author":"Benyamin","year":"2008","journal-title":"Pain Physician"},{"issue":"5","key":"2022112701101033700_lgab011-B21","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/j.1365-2354.2008.00917.x","article-title":"Therapeutic use of Cannabis sativa on chemotherapy-induced nausea and vomiting among cancer patients: systematic review and meta-analysis","volume":"17","author":"Machado Rocha","year":"2008","journal-title":"Eur J Cancer Care (Engl)"},{"issue":"4","key":"2022112701101033700_lgab011-B22","doi-asserted-by":"crossref","first-page":"445","DOI":"10.4103\/IJPC.IJPC_82_17","article-title":"Quality of life among cancer patients","volume":"23","author":"Nayak","year":"2017","journal-title":"Indian J Palliat Care"},{"issue":"9","key":"2022112701101033700_lgab011-B23","doi-asserted-by":"crossref","first-page":"3825","DOI":"10.1073\/pnas.89.9.3825","article-title":"Cannabinoids inhibit N-type calcium channels in neuroblastoma-glioma cells","volume":"89","author":"Mackie","year":"1992","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"2022112701101033700_lgab011-B24","first-page":"121","article-title":"Cannabinoids modulate potassium current in cultured hippocampal neurons","volume":"1","author":"Deadwyler","year":"1993","journal-title":"Recept Channels"},{"issue":"2","key":"2022112701101033700_lgab011-B25","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.neuroimage.2009.06.059","article-title":"Quantitation of cannabinoid CB1 receptors in healthy human brain using positron emission tomography and an inverse agonist radioligand","volume":"48","author":"Terry","year":"2009","journal-title":"Neuroimage"},{"issue":"3","key":"2022112701101033700_lgab011-B26","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1038\/npp.2008.120","article-title":"Smoked medicinal cannabis for neuropathic pain in HIV: a randomized, crossover clinical trial","volume":"34","author":"Ellis","year":"2009","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"2022112701101033700_lgab011-B27","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.jpain.2012.10.009","article-title":"Low-dose vaporized cannabis significantly improves neuropathic pain","volume":"14","author":"Wilsey","year":"2013","journal-title":"J Pain"},{"issue":"9","key":"2022112701101033700_lgab011-B28","first-page":"982","article-title":"An exploratory human laboratory experiment evaluating vaporized cannabis in the treatment\u2009of\u2009neuropathic pain from\u2009spinal\u2009cord\u2009injury\u2009and\u2009disease","volume":"17","author":"Wilsey","year":"2016","journal-title":"J\u2009Pain"},{"issue":"7","key":"2022112701101033700_lgab011-B29","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.jpain.2015.03.008","article-title":"Efficacy of inhaled cannabis on painful diabetic neuropathy","volume":"16","author":"Wallace","year":"2015","journal-title":"J Pain"},{"issue":"9","key":"2022112701101033700_lgab011-B30","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1038\/npp.2017.51","article-title":"Opioid-sparing effect of cannabinoids: a systematic review and meta-analysis","volume":"42","author":"Nielsen","year":"2017","journal-title":"Neuropsychopharmacology"},{"key":"2022112701101033700_lgab011-B31","doi-asserted-by":"crossref","first-page":"110065","DOI":"10.1016\/j.pnpbp.2020.110065","article-title":"Opioid-sparing effects of cannabinoids: myth or reality?","volume":"106","author":"Le Foll","year":"2021","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"3","key":"2022112701101033700_lgab011-B32","doi-asserted-by":"crossref","first-page":"239","DOI":"10.2174\/157015906778019527","article-title":"Role of the cannabinoid system in pain control and therapeutic implications for the management of acute and chronic pain episodes","volume":"4","author":"Manzanares","year":"2006","journal-title":"Curr Neuropharmacol"},{"issue":"2","key":"2022112701101033700_lgab011-B33","first-page":"415","article-title":"Marihuana and pain","volume":"188","author":"Hill","year":"1974","journal-title":"J Pharmacol Exp Ther"},{"issue":"S1","key":"2022112701101033700_lgab011-B34","doi-asserted-by":"crossref","first-page":"299S","DOI":"10.1002\/j.1552-4604.1981.tb02608.x","article-title":"Effects of moderate and high doses of marihuana on thermal pain: a sensory decision theory analysis","volume":"21","author":"Clark","year":"1981","journal-title":"J Clin Pharmacol"},{"issue":"5","key":"2022112701101033700_lgab011-B35","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1097\/01.anes.0000286986.92475.b7","article-title":"Dose-dependent effects of smoked cannabis on capsaicin-induced pain and hyperalgesia in healthy volunteers","volume":"107","author":"Wallace","year":"2007","journal-title":"Anesthesiology"},{"issue":"11-12","key":"2022112701101033700_lgab011-B36","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/j.jpain.2020.03.003","article-title":"A secondary analysis from a randomized trial on the effect of plasma tetrahydrocannabinol levels on pain reduction in painful diabetic peripheral neuropathy","volume":"21","author":"Wallace","year":"2020","journal-title":"J Pain"},{"issue":"1","key":"2022112701101033700_lgab011-B37","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1002\/cpt197518184","article-title":"The analgesic properties of delta-9-tetrahydrocannabinol and codeine","volume":"18","author":"Noyes","year":"1975","journal-title":"Clin Pharmacol Ther"},{"issue":"2-3","key":"2022112701101033700_lgab011-B38","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/j.1552-4604.1975.tb02348.x","article-title":"Analgesic effect of delta-9-tetrahydrocannabinol","volume":"15","author":"Noyes","year":"1975","journal-title":"J Clin Pharmacol"},{"key":"2022112701101033700_lgab011-B39","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1586\/ern.11.27","article-title":"Sativex((R)) (tetrahydrocannabinol + cannabidiol), an endocannabinoid system modulator: basic features and main clinical data","volume":"11","author":"Vermersch","year":"2011","journal-title":"Expert Rev Neurother"},{"issue":"2","key":"2022112701101033700_lgab011-B40","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jpainsymman.2009.06.008","article-title":"Multicenter, double-blind, randomized, placebo-controlled, parallel-group study of the efficacy, safety, and tolerability of THC:CBD extract and THC extract in patients with intractable cancer-related pain","volume":"39","author":"Johnson","year":"2010","journal-title":"J Pain Symptom Manage"},{"issue":"5","key":"2022112701101033700_lgab011-B41","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.jpain.2012.01.003","article-title":"Nabiximols for opioid-treated cancer patients with poorly-controlled chronic pain: a randomized, placebo-controlled, graded-dose trial","volume":"13","author":"Portenoy","year":"2012","journal-title":"J Pain"},{"issue":"3","key":"2022112701101033700_lgab011-B42","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1177\/2049463717710042","article-title":"Sativex oromucosal spray as adjunctive therapy in advanced cancer patients with chronic pain unalleviated by optimized opioid therapy: two double-blind, randomized, placebo-controlled phase 3 studies","volume":"11","author":"Fallon","year":"2017","journal-title":"Br J Pain"},{"issue":"2","key":"2022112701101033700_lgab011-B43","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jpainsymman.2017.09.001","article-title":"Results of a double-blind, randomized, placebo-controlled study of nabiximols oromucosal spray as an adjunctive therapy in advanced cancer patients with chronic uncontrolled pain","volume":"55","author":"Lichtman","year":"2018","journal-title":"J Pain Symptom Manage"},{"issue":"8","key":"2022112701101033700_lgab011-B44","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1002\/cbdv.200790152","article-title":"Human cannabinoid pharmacokinetics","volume":"4","author":"Huestis","year":"2007","journal-title":"Chem Biodivers"},{"issue":"45","key":"2022112701101033700_lgab011-B45","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.15585\/mmwr.mm6845e1","article-title":"Risk factors for e-cigarette, or vaping, Product Use-Associated Lung Injury (EVALI) among adults who use e-cigarette, or vaping, products - Illinois, July-October 2019","volume":"68","author":"Navon","year":"2019","journal-title":"MMWR Morb Mortal Wkly Rep."},{"key":"2022112701101033700_lgab011-B46","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1477-7517-4-11","article-title":"Decreased respiratory symptoms in cannabis users who vaporize","volume":"4","author":"Earleywine","year":"2007","journal-title":"Harm Reduct J"},{"issue":"6","key":"2022112701101033700_lgab011-B47","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.3201\/eid2606.191570","article-title":"Cannabis use and fungal infections in a commercially insured population, United States, 2016","volume":"26","author":"Benedict","year":"2020","journal-title":"Emerg Infect Dis"},{"issue":"4","key":"2022112701101033700_lgab011-B48","doi-asserted-by":"crossref","first-page":"327","DOI":"10.2165\/00003088-200342040-00003","article-title":"Pharmacokinetics and pharmacodynamics of cannabinoids","volume":"42","author":"Grotenhermen","year":"2003","journal-title":"Clin Pharmacokinet"},{"issue":"11-12","key":"2022112701101033700_lgab011-B49","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/j.jpain.2020.03.003","article-title":"A secondary analysis from a randomized trial on the effect of plasma tetrahydrocannabinol levels on pain reduction in painful diabetic peripheral neuropathy","volume":"21","author":"Wallace","year":"2020","journal-title":"J Pain"},{"issue":"8","key":"2022112701101033700_lgab011-B50","doi-asserted-by":"crossref","first-page":"917","DOI":"10.2174\/092986707780363023","article-title":"The role of the cannabinoid CB2 receptor in pain transmission and therapeutic potential of small molecule CB2 receptor agonists","volume":"14","author":"Whiteside","year":"2007","journal-title":"Curr Med Chem"},{"key":"2022112701101033700_lgab011-B51","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.ejphar.2013.09.068","article-title":"Regulation of nausea and vomiting by cannabinoids and the endocannabinoid system","volume":"722","author":"Sharkey","year":"2014","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"2022112701101033700_lgab011-B52","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1093\/annonc\/mdj078","article-title":"Prevention of chemotherapy- and radiotherapy-induced emesis: results of the 2004 Perugia International Antiemetic Consensus Conference","volume":"17","author":"Roila","year":"2006","journal-title":"Ann Oncol"},{"issue":"11","key":"2022112701101033700_lgab011-B53","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1016\/j.annonc.2020.07.020","article-title":"Oral THC:CBD cannabis extract for refractory chemotherapy-induced nausea and vomiting: a randomised, placebo-controlled, phase II crossover trial","volume":"31","author":"Grimison","year":"2020","journal-title":"Ann Oncol"},{"issue":"7","key":"2022112701101033700_lgab011-B54","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1002\/1097-0142(19810401)47:7<1746::AID-CNCR2820470704>3.0.CO;2-4","article-title":"A prospective evaluation of delta-9-tetrahydrocannabinol as an antiemetic in patients receiving adriamycin and cytoxan chemotherapy","volume":"47","author":"Shiling","year":"1981","journal-title":"Cancer"},{"issue":"16","key":"2022112701101033700_lgab011-B55","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1056\/NEJM197510162931603","article-title":"Antiemetic effect of delta-9-tetrahydrocannabinol in patients receiving cancer chemotherapy","volume":"293","author":"Sallan","year":"1975","journal-title":"N Engl J Med"},{"issue":"7303","key":"2022112701101033700_lgab011-B56","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1136\/bmj.323.7303.16","article-title":"Cannabinoids for control of chemotherapy induced nausea and vomiting: quantitative systematic review","volume":"323","author":"Tram\u00e8r","year":"2001","journal-title":"BMJ"},{"issue":"5","key":"2022112701101033700_lgab011-B57","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1111\/j.1365-2125.2010.03743.x","article-title":"Preliminary efficacy and safety of an oromucosal standardized cannabis extract in chemotherapy-induced nausea and vomiting","volume":"70","author":"Duran","year":"2010","journal-title":"Br J Clin Pharmacol"},{"key":"2022112701101033700_lgab011-B58","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0305-7372(82)80036-4","article-title":"Nabilone vs. placebo in the treatment of chemotherapy-induced nausea and vomiting in cancer patients","volume":"9(Suppl B","author":"Levitt","year":"1982","journal-title":"Cancer Treat Rev"},{"issue":"7","key":"2022112701101033700_lgab011-B59","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.amjmed.2017.12.041","article-title":"Cannabinoids in patients with nausea and vomiting associated with malignancy and its treatments","volume":"131","author":"Garcia","year":"2018","journal-title":"Am J Med"},{"issue":"11","key":"2022112701101033700_lgab011-B60","first-page":"CD009464","article-title":"Cannabinoids for nausea and vomiting in adults with cancer receiving chemotherapy","author":"Smith","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"issue":"S1","key":"2022112701101033700_lgab011-B61","doi-asserted-by":"crossref","first-page":"64S","DOI":"10.1002\/j.1552-4604.1981.tb02576.x","article-title":"Nabilone: an effective antiemetic in patients receiving cancer chemotherapy","volume":"21","author":"Einhorn","year":"1981","journal-title":"J Clin Pharmacol"},{"issue":"1","key":"2022112701101033700_lgab011-B62","first-page":"163","article-title":"Antiemetic therapy: a review of recent studies and a report of a random assignment trial comparing metoclopramide with delta-9-tetrahydrocannabinol","volume":"68","author":"Gralla","year":"1984","journal-title":"Cancer Treat Rep"},{"key":"2022112701101033700_lgab011-B63","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0305-7372(82)80032-7","article-title":"A double-blind, controlled trial of nabilone vs. prochlorperazine for refractory emesis induced by cancer chemotherapy","volume":"9(Suppl B","author":"Johansson","year":"1982","journal-title":"Cancer Treat Rev"},{"issue":"3","key":"2022112701101033700_lgab011-B64","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1185\/030079907X167525","article-title":"Efficacy of dronabinol alone and in combination with ondansetron versus ondansetron alone for delayed chemotherapy-induced nausea and vomiting","volume":"23","author":"Meiri","year":"2007","journal-title":"Curr Med Res Opin"},{"issue":"24","key":"2022112701101033700_lgab011-B65","doi-asserted-by":"crossref","first-page":"2782","DOI":"10.1200\/JCO.20.01296","article-title":"Antiemetics: ASCO guideline update","volume":"38","author":"Hesketh","year":"2020","journal-title":"J Clin Oncol"},{"key":"2022112701101033700_lgab011-B66","doi-asserted-by":"crossref","first-page":"v119","DOI":"10.1093\/annonc\/mdw270","article-title":"2016 MASCC and ESMO guideline update for the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting and of nausea and vomiting in advanced cancer patients","volume":"27(suppl 5","author":"Roila","year":"2016","journal-title":"Ann Oncol"},{"issue":"5","key":"2022112701101033700_lgab011-B67","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","article-title":"Definition and classification of cancer cachexia: an international consensus","volume":"12","author":"Fearon","year":"2011","journal-title":"Lancet Oncol"},{"issue":"2","key":"2022112701101033700_lgab011-B68","doi-asserted-by":"crossref","first-page":"216","DOI":"10.21037\/apm.2020.02.06","article-title":"Symptom burden and characteristics of patients who die in the acute palliative care unit of a tertiary cancer center","volume":"9","author":"Ahn","year":"2020","journal-title":"Ann Palliat Med"},{"issue":"9","key":"2022112701101033700_lgab011-B69","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/S1470-2045(09)70200-1","article-title":"Baseline quality of life as a prognostic indicator of survival: a meta-analysis of individual patient data from EORTC clinical trials","volume":"10","author":"Quinten","year":"2009","journal-title":"Lancet Oncol"},{"issue":"2","key":"2022112701101033700_lgab011-B70","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1002\/cncr.28382","article-title":"A global analysis of multitrial data investigating quality of life and symptoms as prognostic factors for survival in different tumor sites","volume":"120","author":"Quinten","year":"2014","journal-title":"Cancer"},{"issue":"4","key":"2022112701101033700_lgab011-B71","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s11864-021-00829-0","article-title":"Should loss of appetite be palliated in patients with advanced cancer?","volume":"22","author":"Ehret","year":"2021","journal-title":"Curr Treat Options Oncol"},{"issue":"4","key":"2022112701101033700_lgab011-B72","doi-asserted-by":"crossref","first-page":"411","DOI":"10.2147\/nano.2006.1.4.411","article-title":"Megestrol acetate in cachexia and anorexia","volume":"1","author":"Yeh","year":"2006","journal-title":"Int J Nanomedicine"},{"issue":"5300","key":"2022112701101033700_lgab011-B73","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1038\/231260b0","article-title":"Effects of marihuana on the solution of anagrams, memory and appetite","volume":"231","author":"Abel","year":"1971","journal-title":"Nature"},{"issue":"1","key":"2022112701101033700_lgab011-B74","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1177\/082585979401000105","article-title":"A phase II study of delta-9-tetrahydrocannabinol for appetite stimulation in cancer-associated anorexia","volume":"10","author":"Nelson","year":"1994","journal-title":"J Palliat Care"},{"key":"2022112701101033700_lgab011-B75","doi-asserted-by":"crossref","first-page":"100497","DOI":"10.1016\/j.gore.2019.100497","article-title":"Non-prescription cannabis use for symptom management amongst women with gynecologic malignancies","volume":"30","author":"Blake","year":"2019","journal-title":"Gynecol Oncol Rep"},{"key":"2022112701101033700_lgab011-B76","doi-asserted-by":"crossref","first-page":"1534735419881498","DOI":"10.1177\/1534735419881498","article-title":"The effects of dosage-controlled cannabis capsules on cancer-related cachexia and anorexia syndrome in advanced cancer patients: pilot study","volume":"18","author":"Bar-Sela","year":"2019","journal-title":"Integr Cancer Ther"},{"issue":"2","key":"2022112701101033700_lgab011-B77","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1200\/JCO.2002.20.2.567","article-title":"Dronabinol versus megestrol acetate versus combination therapy for cancer-associated anorexia: a North Central Cancer Treatment Group study","volume":"20","author":"Jatoi","year":"2002","journal-title":"J Clin Oncol"},{"issue":"9","key":"2022112701101033700_lgab011-B78","doi-asserted-by":"crossref","first-page":"6091","DOI":"10.1021\/acsomega.7b00996","article-title":"Chemical profiling of medical cannabis extracts","volume":"2","author":"Lewis","year":"2017","journal-title":"ACS Omega"},{"issue":"21","key":"2022112701101033700_lgab011-B79","doi-asserted-by":"crossref","first-page":"3394","DOI":"10.1200\/JCO.2005.05.1847","article-title":"Comparison of orally administered cannabis extract and delta-9-tetrahydrocannabinol in treating patients with cancer-related anorexia-cachexia syndrome: a multicenter, phase III, randomized, double-blind, placebo-controlled clinical trial from the Cannabis-In-Cachexia-Study-Group","volume":"24","author":"Strasser","year":"2006","journal-title":"J Clin Oncol"},{"key":"2022112701101033700_lgab011-B80","volume-title":"Dying to Get High, Marijuana as Medicine","author":"Chapkis","year":"2008"},{"key":"2022112701101033700_lgab011-B81","author":"Vedantam","year":"2020"},{"key":"2022112701101033700_lgab011-B82","year":"2009"},{"issue":"7","key":"2022112701101033700_lgab011-B83","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1002\/pon.5054","article-title":"Quality of life versus length of life considerations in cancer patients: a systematic literature review","volume":"28","author":"Shrestha","year":"2019","journal-title":"Psychooncology"},{"issue":"7","key":"2022112701101033700_lgab011-B84","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1002\/hup.1048","article-title":"Cannabis and anxiety: a critical review of the evidence","volume":"24","author":"Crippa","year":"2009","journal-title":"Hum Psychopharmacol"},{"issue":"1","key":"2022112701101033700_lgab011-B85","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s12954-019-0278-6","article-title":"Medical cannabis patterns of use and substitution for opioids & other pharmaceutical drugs, alcohol, tobacco, and illicit substances; results from a cross-sectional survey of authorized patients","volume":"16","author":"Lucas","year":"2019","journal-title":"Harm Reduct J"},{"issue":"2","key":"2022112701101033700_lgab011-B86","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1080\/02791072.2011.587700","article-title":"Who are medical marijuana patients? Population characteristics from nine California assessment clinics","volume":"43","author":"Reinarman","year":"2011","journal-title":"J Psychoactive Drugs"},{"issue":"1","key":"2022112701101033700_lgab011-B87","first-page":"1","article-title":"An analysis of applicants presenting to a medical marijuana specialty practice in California","volume":"4","author":"Nunberg","year":"2011","journal-title":"J Drug Policy Anal"},{"issue":"1","key":"2022112701101033700_lgab011-B88","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1089\/can.2016.0007","article-title":"A cross-sectional survey of medical cannabis users: patterns of use and perceived efficacy","volume":"1","author":"Sexton","year":"2016","journal-title":"Cannabis Cannabinoid Res"},{"issue":"6","key":"2022112701101033700_lgab011-B89","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.drugpo.2013.08.010","article-title":"Cannabis for therapeutic purposes: patient characteristics, access, and reasons for use","volume":"24","author":"Walsh","year":"2013","journal-title":"Int J Drug Policy"},{"issue":"1","key":"2022112701101033700_lgab011-B90","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3109\/00952990.2013.821477","article-title":"Self-reported cannabis use characteristics, patterns and helpfulness among medical cannabis users","volume":"40","author":"Bonn-Miller","year":"2014","journal-title":"Am J Drug Alcohol Abuse"},{"issue":"6","key":"2022112701101033700_lgab011-B91","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1177\/1049909112454215","article-title":"Prospectively surveying health-related quality of life and symptom relief in a lot-based sample of medical cannabis-using patients in urban Washington State reveals managed chronic illness and debility","volume":"30","author":"Aggarwal","year":"2013","journal-title":"Am J Hosp Palliat Care"},{"key":"2022112701101033700_lgab011-B92","doi-asserted-by":"crossref","first-page":"989","DOI":"10.2147\/JPR.S134330","article-title":"Cannabis as a substitute for prescription drugs- a cross sectional study","volume":"10","author":"Corroon","year":"2017","journal-title":"J Pain Res"},{"issue":"7","key":"2022112701101033700_lgab011-B93","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.jpain.2019.01.010","article-title":"Pills to pot: observational analyses of cannabis substitution among medical cannabis users with chronic pain","volume":"20","author":"Boehnke","year":"2019","journal-title":"J Pain"},{"issue":"9","key":"2022112701101033700_lgab011-B94","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1111\/febs.12260","article-title":"Modulating the endocannabinoid system in human health and disease--successes and failures","volume":"280","author":"Pacher","year":"2013","journal-title":"FEBS J"},{"key":"2022112701101033700_lgab011-B95","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ejim.2018.01.003","article-title":"The therapeutic effects of cannabis and cannabinoids: an update from the National Academies of Sciences, Engineering and Medicine Report","volume":"49","author":"Abrams","year":"2018","journal-title":"Eur J Intern Med"},{"key":"2022112701101033700_lgab011-B96","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.cpr.2016.10.002","article-title":"Medical cannabis and mental health: a guided systematic review","volume":"51","author":"Walsh","year":"2017","journal-title":"Clin Psychol Rev"},{"key":"2022112701101033700_lgab011-B97","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2013\/510392","article-title":"The medical necessity for medicinal cannabis: prospective, observational study evaluating the treatment in cancer patients on supportive or palliative care","volume":"2013","author":"Bar-Sela","year":"2013","journal-title":"Evid Based Complement Alternat Med"},{"key":"2022112701101033700_lgab011-B98","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ejim.2018.01.023","article-title":"Prospective analysis of safety and efficacy of medical cannabis in large unselected population of patients with cancer","volume":"49","author":"Bar-Lev Schleider","year":"2018","journal-title":"Eur J Intern Med"},{"issue":"19","key":"2022112701101033700_lgab011-B99","doi-asserted-by":"crossref","first-page":"3242","DOI":"10.1111\/bph.13724","article-title":"Cannabidiol regulation of emotion and emotional memory processing: relevance for treating anxiety-related and substance abuse disorders","volume":"174","author":"Lee","year":"2017","journal-title":"Br J Pharmacol"},{"issue":"4","key":"2022112701101033700_lgab011-B100","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1007\/BF02244012","article-title":"Antianxiety effect of cannabidiol in the elevated plus-maze","volume":"100","author":"Guimaraes","year":"1990","journal-title":"Psychopharmacology (Berl)"},{"issue":"3","key":"2022112701101033700_lgab011-B101","first-page":"1002","article-title":"Pharmacological characterization of cannabinoids in the elevated plus maze","volume":"253","author":"Onaivi","year":"1990","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"2022112701101033700_lgab011-B102","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s00213-012-2878-7","article-title":"Involvement of serotonin-mediated neurotransmission in the dorsal periaqueductal gray matter on cannabidiol chronic effects in panic-like responses in rats","volume":"226","author":"Campos","year":"2013","journal-title":"Psychopharmacology (Berl)"},{"issue":"6","key":"2022112701101033700_lgab011-B103","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1038\/npp.2011.6","article-title":"Cannabidiol reduces the anxiety induced by simulated public speaking in treatment-naive social phobia patients","volume":"36","author":"Bergamaschi","year":"2011","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"2022112701101033700_lgab011-B104","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1177\/0269881110379283","article-title":"Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder: a preliminary report","volume":"25","author":"Crippa","year":"2011","journal-title":"J Psychopharmacol"},{"issue":"7","key":"2022112701101033700_lgab011-B105","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1007\/s00213-021-05823-w","article-title":"Evaluating cannabidiol (CBD) expectancy effects on acute stress and anxiety in healthy adults: a randomized crossover study","volume":"238","author":"Spinella","year":"2021","journal-title":"Psychopharmacology (Berl)"},{"issue":"5","key":"2022112701101033700_lgab011-B106","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1002\/cpt.2071","article-title":"Cannabidiol and abnormal liver chemistries in healthy adults: results of a phase I clinical trial","volume":"109","author":"Watkins","year":"2020","journal-title":"Clin Pharmacol Ther"},{"issue":"4","key":"2022112701101033700_lgab011-B107","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s11920-017-0775-9","article-title":"Cannabis, cannabinoids, and sleep: a review of the literature","volume":"19","author":"Babson","year":"2017","journal-title":"Curr Psychiatry Rep"},{"issue":"6","key":"2022112701101033700_lgab011-B108","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.smrv.2014.02.005","article-title":"The effects of cannabinoid administration on sleep: a systematic review of human studies","volume":"18","author":"Gates","year":"2014","journal-title":"Sleep Med Rev"},{"key":"2022112701101033700_lgab011-B109","volume-title":"The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research","year":"2017"},{"key":"2022112701101033700_lgab011-B110","doi-asserted-by":"crossref","first-page":"315","DOI":"10.3389\/fphar.2018.00315","article-title":"No acute effects of cannabidiol on the sleep-wake cycle of healthy subjects: a randomized, double-blind, placebo-controlled, crossover study","volume":"9","author":"Linares","year":"2018","journal-title":"Front Pharmacol"},{"issue":"3","key":"2022112701101033700_lgab011-B111","doi-asserted-by":"crossref","first-page":"269","DOI":"10.2174\/1570159X11666131204235805","article-title":"Potential effects of cannabidiol as a wake-promoting agent","volume":"12","author":"Murillo-Rodr\u00edguez","year":"2014","journal-title":"Curr Neuropharmacol"},{"key":"2022112701101033700_lgab011-B112","doi-asserted-by":"crossref","first-page":"101339","DOI":"10.1016\/j.smrv.2020.101339","article-title":"Cannabinoid therapies in the management of sleep disorders: a systematic review of preclinical and clinical studies","volume":"53","author":"Suraev","year":"2020","journal-title":"Sleep Med Rev"},{"issue":"1","key":"2022112701101033700_lgab011-B113","doi-asserted-by":"crossref","first-page":"zsx184","DOI":"10.1093\/sleep\/zsx184","article-title":"Pharmacotherapy of apnea by cannabimimetic enhancement, the PACE clinical trial: effects of dronabinol in obstructive sleep apnea","volume":"41","author":"Carley","year":"2018","journal-title":"Sleep"},{"key":"2022112701101033700_lgab011-B114","first-page":"2470547019864096","article-title":"Endocannabinoid system alterations in posttraumatic stress disorder: a review of developmental and accumulative effects of trauma","volume":"3","author":"Bassir Nia","year":"2019","journal-title":"Chronic Stress (Thousand Oaks)"},{"key":"2022112701101033700_lgab011-B115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbi.2014.06.007","article-title":"The endocannabinoid system modulates stress, emotionality, and inflammation","volume":"42","author":"Crowe","year":"2014","journal-title":"Brain Behav Immun"},{"key":"2022112701101033700_lgab011-B116","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/978-3-540-88955-7_14","article-title":"Role of endocannabinoid signaling in anxiety and depression","volume":"1","author":"Patel","year":"2009","journal-title":"Curr Top Behav Neurosci"},{"issue":"11","key":"2022112701101033700_lgab011-B117","doi-asserted-by":"crossref","first-page":"2821","DOI":"10.1111\/j.1460-9568.2008.06266.x","article-title":"Adaptations in endocannabinoid signaling in response to repeated homotypic stress: a novel mechanism for stress habituation","volume":"27","author":"Patel","year":"2008","journal-title":"Eur J Neurosci"},{"issue":"1","key":"2022112701101033700_lgab011-B118","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1186\/s12888-020-02813-8","article-title":"Effects of (9)-tetrahydrocannabinol on aversive memories and anxiety: a review from human studies","volume":"20","author":"Raymundi","year":"2020","journal-title":"BMC Psychiatry"},{"issue":"1","key":"2022112701101033700_lgab011-B119","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1476-5381.2009.00515.x","article-title":"Evidence that the plant cannabinoid cannabigerol is a highly potent alpha2-adrenoceptor agonist and moderately potent 5HT1A receptor antagonist","volume":"159","author":"Cascio","year":"2010","journal-title":"Br J Pharmacol"},{"key":"2022112701101033700_lgab011-B120","doi-asserted-by":"crossref","first-page":"632","DOI":"10.3389\/fphar.2018.00632","article-title":"Cannabigerol action at cannabinoid CB1 and CB2 receptors and at CB1-CB2 heteroreceptor complexes","volume":"9","author":"Navarro","year":"2018","journal-title":"Front Pharmacol"},{"issue":"7","key":"2022112701101033700_lgab011-B121","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1111\/j.1476-5381.2010.01166.x","article-title":"Effects of cannabinoids and cannabinoid-enriched cannabis extracts on TRP channels and endocannabinoid metabolic enzymes","volume":"163","author":"De Petrocellis","year":"2011","journal-title":"Br J Pharmacol"},{"issue":"23","key":"2022112701101033700_lgab011-B122","doi-asserted-by":"crossref","first-page":"4537","DOI":"10.1111\/bph.14815","article-title":"Cannabichromene is a cannabinoid CB2 receptor agonist","volume":"176","author":"Udoh","year":"2019","journal-title":"Br J Pharmacol"},{"issue":"3","key":"2022112701101033700_lgab011-B123","first-page":"1046","article-title":"Pharmacology and stereoselectivity of structurally novel cannabinoids in mice","volume":"247","author":"Little","year":"1988","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"2022112701101033700_lgab011-B124","doi-asserted-by":"crossref","first-page":"20405","DOI":"10.1038\/s41598-020-77175-y","article-title":"In vitro and in vivo pharmacological activity of minor cannabinoids isolated from Cannabis sativa","volume":"10","author":"Zagzoog","year":"2020","journal-title":"Sci Rep"},{"issue":"6","key":"2022112701101033700_lgab011-B125","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1055\/s-2000-8616","article-title":"Bioavailability and pharmacokinetics of natural volatile terpenes in animals and humans","volume":"66","author":"Kohlert","year":"2000","journal-title":"Planta Med"},{"issue":"1","key":"2022112701101033700_lgab011-B126","doi-asserted-by":"crossref","first-page":"8232","DOI":"10.1038\/s41598-021-87740-8","article-title":"Cannabis sativa terpenes are cannabimimetic and selectively enhance cannabinoid activity","volume":"11","author":"LaVigne","year":"2021","journal-title":"Sci Rep"},{"issue":"4","key":"2022112701101033700_lgab011-B127","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.euroneuro.2013.10.008","article-title":"The cannabinoid CB(2) receptor-selective phytocannabinoid beta-caryophyllene exerts analgesic effects in mouse models of inflammatory and neuropathic pain","volume":"24","author":"Klauke","year":"2014","journal-title":"Eur Neuropsychopharmacol"},{"issue":"8-9","key":"2022112701101033700_lgab011-B128","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.phymed.2009.10.002","article-title":"Effects of inhaled linalool in anxiety, social interaction and aggressive behavior in mice","volume":"17","author":"Linck","year":"2010","journal-title":"Phytomedicine"},{"issue":"4","key":"2022112701101033700_lgab011-B129","doi-asserted-by":"crossref","first-page":"147","DOI":"10.9740\/mhc.2017.07.147","article-title":"Essential oil of lavender in anxiety disorders: ready for prime time?","volume":"7","author":"Malcolm","year":"2017","journal-title":"Ment Health Clin"},{"issue":"8-9","key":"2022112701101033700_lgab011-B130","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.phymed.2012.02.013","article-title":"Is lavender an anxiolytic drug? A systematic review of randomised clinical trials","volume":"19","author":"Perry","year":"2012","journal-title":"Phytomedicine"},{"issue":"4","key":"2022112701101033700_lgab011-B131","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1007\/s11418-012-0732-1","article-title":"The sedative effect of inhaled terpinolene in mice and its structure-activity relationships","volume":"67","author":"Ito","year":"2013","journal-title":"J Nat Med"},{"issue":"7","key":"2022112701101033700_lgab011-B132","doi-asserted-by":"crossref","first-page":"e5103","DOI":"10.1590\/1414-431x20165103","article-title":"Association of terpinolene and diclofenac presents antinociceptive and anti-inflammatory synergistic effects in a model of chronic inflammation","volume":"49","author":"Macedo","year":"2016","journal-title":"Braz J Med Biol Res"},{"issue":"2","key":"2022112701101033700_lgab011-B133","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.bbr.2006.05.006","article-title":"Lemon oil vapor causes an anti-stress effect via modulating the 5-HT and DA activities in mice","volume":"172","author":"Komiya","year":"2006","journal-title":"Behav Brain Res"},{"issue":"4","key":"2022112701101033700_lgab011-B134","doi-asserted-by":"crossref","first-page":"367","DOI":"10.3177\/jnsv.55.367","article-title":"Sub-chronic effects of s-limonene on brain neurotransmitter levels and behavior of rats","volume":"55","author":"Zhou","year":"2009","journal-title":"J Nutr Sci Vitaminol (Tokyo)"},{"issue":"3","key":"2022112701101033700_lgab011-B135","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1159\/000096889","article-title":"Effects of citrus fragrance on immune function and depressive states","volume":"2","author":"Komori","year":"1995","journal-title":"Neuroimmunomodulation"},{"issue":"4","key":"2022112701101033700_lgab011-B136","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1055\/s-0043-119361","article-title":"Evaluation of cannabinoid and terpenoid content: cannabis flower compared to supercritical CO2 concentrate","volume":"84","author":"Sexton","year":"2018","journal-title":"Planta Med"},{"issue":"2","key":"2022112701101033700_lgab011-B137","doi-asserted-by":"crossref","first-page":"97","DOI":"10.5487\/TR.2017.33.2.097","article-title":"Terpenes from forests and human health","volume":"33","author":"Cho","year":"2017","journal-title":"Toxicol Res"},{"issue":"12","key":"2022112701101033700_lgab011-B138","doi-asserted-by":"crossref","first-page":"435","DOI":"10.3390\/ph13120435","article-title":"Short-term medical cannabis treatment regimens produced beneficial effects among palliative cancer patients","volume":"13","author":"Aviram","year":"2020","journal-title":"Pharmaceuticals (Basel)"},{"issue":"22","key":"2022112701101033700_lgab011-B139","doi-asserted-by":"crossref","first-page":"4488","DOI":"10.1002\/cncr.30879","article-title":"Cannabis use among patients at a comprehensive cancer center in a state with legalized medicinal and recreational use","volume":"123","author":"Pergam","year":"2017","journal-title":"Cancer"},{"issue":"3","key":"2022112701101033700_lgab011-B140","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1007\/s00520-014-2429-3","article-title":"Inhaled medicinal cannabis and the immunocompromised","volume":"23","author":"Ruchlemer","year":"2015","journal-title":"Support Care Cancer"},{"issue":"1","key":"2022112701101033700_lgab011-B141","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1159\/000507998","article-title":"Delta-9-tetrahydrocannabinol and cannabidiol drug-drug interactions","volume":"3","author":"Kocis","year":"2020","journal-title":"Med Cannabis Cannabinoids"},{"key":"2022112701101033700_lgab011-B142","author":"Rappold","year":"2014"},{"issue":"19","key":"2022112701101033700_lgab011-B143","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1200\/JCO.2017.76.1221","article-title":"Medical oncologists\u2019 beliefs, practices an knowledge regarding marijuana used therapeutically: a nationally representative survey study","volume":"36","author":"Braun","year":"2018","journal-title":"J Clin Oncol"},{"key":"2022112701101033700_lgab011-B144","author":"Alliance","year":"2018"},{"key":"2022112701101033700_lgab011-B145","year":"2013"},{"key":"2022112701101033700_lgab011-B146","volume-title":"Cannabis, a Handbook for Nurses","author":"Clark","year":"2021"},{"issue":"2","key":"2022112701101033700_lgab011-B147","first-page":"S19","article-title":"The NCSBN National Nursing Guidelines for Medical Marijuana","volume":"9","author":"Committee","year":"2018","journal-title":"J Nurs Regul"},{"key":"2022112701101033700_lgab011-B148","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ejim.2018.01.004","article-title":"Practical considerations in medical cannabis administration and dosing","volume":"49","author":"MacCallum","year":"2018","journal-title":"Eur J Intern Med"},{"issue":"3","key":"2022112701101033700_lgab011-B149","doi-asserted-by":"crossref","first-page":"373","DOI":"10.3390\/cancers11030373","article-title":"Cancer-related neuropathic pain","volume":"11","author":"Edwards","year":"2019","journal-title":"Cancers (Basel)"},{"key":"2022112701101033700_lgab011-B150","first-page":"6","article-title":"Interactions of the opioid and cannabinoid systems in reward: insights from knockout studies","volume":"6","author":"Befort","year":"2015","journal-title":"Front Pharmacol"},{"issue":"2","key":"2022112701101033700_lgab011-B151","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1155\/2001\/469629","article-title":"Medicinal use of cannabis: history and current status","volume":"6","author":"Kalant","year":"2001","journal-title":"Pain Res Manag"},{"issue":"9","key":"2022112701101033700_lgab011-B152","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1093\/annonc\/mdq727","article-title":"Delta-9-tetrahydrocannabinol may palliate altered chemosensory perception in cancer patients: results of a randomized, double-blind, placebo-controlled pilot trial","volume":"22","author":"Brisbois","year":"2011","journal-title":"Ann Oncol"},{"key":"2022112701101033700_lgab011-B153","article-title":"Investigating the neuroendocrine and behavioral controls of cannabis-induced feeding behavior","author":"Davis","year":"2018","journal-title":"Society for the Study of Ingest Behavior"},{"key":"2022112701101033700_lgab011-B154","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.brainres.2011.11.001","article-title":"A pilot study of the effects of cannabis on appetite hormones in HIV-infected adult men","volume":"1431","author":"Riggs","year":"2012","journal-title":"Brain Res"},{"issue":"3","key":"2022112701101033700_lgab011-B155","doi-asserted-by":"crossref","first-page":"216","DOI":"10.3109\/15360288.2014.941130","article-title":"The pharmacokinetics, efficacy, safety, and ease of use of a novel portable metered-dose cannabis inhaler in patients with chronic neuropathic pain: a phase 1a study","volume":"28","author":"Eisenberg","year":"2014","journal-title":"J Pain Palliat Care Pharmacother"},{"issue":"2","key":"2022112701101033700_lgab011-B156","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s11864-020-00811-2","article-title":"Medical cannabis in oncology: a valuable unappreciated remedy or an undesirable risk?","volume":"22","author":"Abu-Amna","year":"2021","journal-title":"Curr Treat Options Oncol"},{"issue":"2","key":"2022112701101033700_lgab011-B157","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/phar.1187","article-title":"The pharmacologic and clinical effects of medical cannabis","volume":"33","author":"Borgelt","year":"2013","journal-title":"Pharmacotherapy"},{"issue":"2","key":"2022112701101033700_lgab011-B158","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3322\/caac.21260","article-title":"Medical marijuana for cancer","volume":"65","author":"Kramer","year":"2015","journal-title":"CA Cancer J Clin"}],"container-title":["JNCI Monographs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jncimono\/article-pdf\/2021\/58\/86\/42539285\/lgab011.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jncimono\/article-pdf\/2021\/58\/86\/42539285\/lgab011.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,26]],"date-time":"2022-11-26T20:12:17Z","timestamp":1669493537000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jncimono\/article\/2021\/58\/86\/6446200"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,27]]},"references-count":158,"journal-issue":{"issue":"58","published-online":{"date-parts":[[2021,11,27]]},"published-print":{"date-parts":[[2021,11,28]]}},"URL":"https:\/\/doi.org\/10.1093\/jncimonographs\/lgab011","relation":{},"ISSN":["1052-6773","1745-6614"],"issn-type":[{"value":"1052-6773","type":"print"},{"value":"1745-6614","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,12,1]]},"published":{"date-parts":[[2021,11,27]]}}}